Drug Shortage Report for DYSPORT AESTHETIC

Last updated on 2022-05-21 History
Report ID 159136
Drug Identification Number 02387735
Brand name DYSPORT AESTHETIC
Common or Proper name abobotulinumtoxinA
Company Name IPSEN BIOPHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) ABOBOTULINUMTOXINA
Strength(s) 300UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 vial
ATC code M03AX
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-05-04
Actual start date 2022-05-04
Estimated end date 2022-05-20
Actual end date 2022-05-20
Shortage status Resolved
Updated date 2022-05-21
Company comments Dysport 300u product has seen a significant increase in demand driven by Aesthetic growth. Ipsen are implementing supply capacity improvement projects in order to meet this new growth. During this interim period there will be stock constraints.
Health Canada comments
Tier 3 Status No
Contact Address 5050 SATELLITE DRIVE
MISSISSAUGA, ONTARIO
CANADA L4W 0G1
Company contact information medinfoandsafetycanada@ipsen.com 1(855) 215-2288

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-05-21 English Compare
v8 2022-05-20 French Compare
v7 2022-05-20 English Compare
v6 2022-05-05 English Compare
v5 2022-04-29 French Compare
v4 2022-04-29 English Compare
v3 2022-04-29 English Compare
v2 2022-04-21 French Compare
v1 2022-04-21 English Compare

Showing 1 to 9 of 9